Seoul, Seoul-t'ukpyolsi, South Korea | Fund Name | Location |
| Acko Technology and Services | - |
| China Trends Holdings | China, Hong Kong, Hong Kong Island |
| Contento BPS | - |
| DIC Corporation | - |
| Ericsson Ventures | California, Santa Clara, United States |
| Expara IDM Ventures | Central, Central Region, Singapore |
| Foundermark | New York, New York, United States |
| Glaxo Group | Brentford, Hounslow, United Kingdom |
| GMV Innovative Solutions | Balearic Islands, Islas Baleares, Spain |
| Huoerguosi Dao Yang Chuangye Touzi | China, Ilin, Jiangsu |
| Mantra Capital | Georgia, Marietta, United States |
| Octava | Georgia, Norcross, United States |
| Onyx Software | Bellevue, United States, Washington |
| S.A.C. Capital Advisors | Connecticut, Stamford, United States |
| Sinovo Venture Capital | China, Shanghai |
| Way Point Capital Partners | New York, Rye, United States |
| Yamaguchi Bank | Japan, Shimonoseki, Yamaguchi Prefecture |
| Yaotian Keji | Beijing, China, Pinggu |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
NeoTX Therapeutics | $45M | 19 Feb 2020 | Rishon Lezion, Center District, Israel |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
NeoTX Therapeutics | $45M | 19 Feb 2020 | Rishon Lezion, Center District, Israel |
